vs

Side-by-side financial comparison of Invesco (IVZ) and Atlassian Corp (TEAM). Click either name above to swap in a different company.

Atlassian Corp is the larger business by last-quarter revenue ($1.8B vs $1.7B, roughly 1.1× Invesco). Atlassian Corp runs the higher net margin — -5.5% vs -58.9%, a 53.4% gap on every dollar of revenue. On growth, Atlassian Corp posted the faster year-over-year revenue change (31.7% vs 6.2%). Atlassian Corp produced more free cash flow last quarter ($561.3M vs $432.2M). Over the past eight quarters, Atlassian Corp's revenue compounded faster (22.6% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

The Dragoneer Investment Group (Dragoneer) is an American investment firm based in San Francisco, California. The firm focuses on technology investments in both public and private markets globally.

IVZ vs TEAM — Head-to-Head

Bigger by revenue
TEAM
TEAM
1.1× larger
TEAM
$1.8B
$1.7B
IVZ
Growing faster (revenue YoY)
TEAM
TEAM
+25.5% gap
TEAM
31.7%
6.2%
IVZ
Higher net margin
TEAM
TEAM
53.4% more per $
TEAM
-5.5%
-58.9%
IVZ
More free cash flow
TEAM
TEAM
$129.1M more FCF
TEAM
$561.3M
$432.2M
IVZ
Faster 2-yr revenue CAGR
TEAM
TEAM
Annualised
TEAM
22.6%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IVZ
IVZ
TEAM
TEAM
Revenue
$1.7B
$1.8B
Net Profit
$-995.9M
$-98.4M
Gross Margin
85.3%
Operating Margin
-86.2%
11.6%
Net Margin
-58.9%
-5.5%
Revenue YoY
6.2%
31.7%
Net Profit YoY
-575.8%
-39.0%
EPS (diluted)
$-2.61
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
TEAM
TEAM
Q1 26
$1.8B
Q4 25
$1.7B
$1.6B
Q3 25
$1.6B
$1.4B
Q2 25
$1.5B
$1.4B
Q1 25
$1.5B
$1.4B
Q4 24
$1.6B
$1.3B
Q3 24
$1.5B
$1.2B
Q2 24
$1.5B
Net Profit
IVZ
IVZ
TEAM
TEAM
Q1 26
$-98.4M
Q4 25
$-995.9M
$-42.6M
Q3 25
$356.4M
$-51.9M
Q2 25
$197.4M
$-23.9M
Q1 25
$171.1M
$-70.8M
Q4 24
$209.3M
$-38.2M
Q3 24
$55.0M
$-123.8M
Q2 24
$132.2M
Gross Margin
IVZ
IVZ
TEAM
TEAM
Q1 26
85.3%
Q4 25
85.0%
Q3 25
82.0%
Q2 25
83.1%
Q1 25
83.8%
Q4 24
82.7%
Q3 24
81.7%
Q2 24
Operating Margin
IVZ
IVZ
TEAM
TEAM
Q1 26
11.6%
Q4 25
-86.2%
-3.0%
Q3 25
16.5%
-6.7%
Q2 25
14.1%
-2.1%
Q1 25
18.1%
-0.9%
Q4 24
19.6%
-4.5%
Q3 24
6.6%
-2.7%
Q2 24
13.9%
Net Margin
IVZ
IVZ
TEAM
TEAM
Q1 26
-5.5%
Q4 25
-58.9%
-2.7%
Q3 25
21.7%
-3.6%
Q2 25
13.0%
-1.7%
Q1 25
11.2%
-5.2%
Q4 24
13.1%
-3.0%
Q3 24
3.6%
-10.4%
Q2 24
8.9%
EPS (diluted)
IVZ
IVZ
TEAM
TEAM
Q1 26
$-0.38
Q4 25
$-2.61
$-0.16
Q3 25
$0.66
$-0.20
Q2 25
$-0.03
$-0.08
Q1 25
$0.38
$-0.27
Q4 24
$0.46
$-0.15
Q3 24
$0.12
$-0.48
Q2 24
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
TEAM
TEAM
Cash + ST InvestmentsLiquidity on hand
$1.0B
$1.1B
Total DebtLower is stronger
$1.8B
$989.1M
Stockholders' EquityBook value
$12.2B
$879.0M
Total Assets
$27.1B
$5.7B
Debt / EquityLower = less leverage
0.15×
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
TEAM
TEAM
Q1 26
$1.1B
Q4 25
$1.0B
$1.6B
Q3 25
$973.1M
$2.8B
Q2 25
$922.7M
$2.9B
Q1 25
$821.7M
$3.0B
Q4 24
$986.5M
$2.5B
Q3 24
$1.0B
$2.2B
Q2 24
$878.5M
Total Debt
IVZ
IVZ
TEAM
TEAM
Q1 26
$989.1M
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Stockholders' Equity
IVZ
IVZ
TEAM
TEAM
Q1 26
$879.0M
Q4 25
$12.2B
$1.6B
Q3 25
$14.0B
$1.4B
Q2 25
$13.9B
$1.3B
Q1 25
$14.7B
$1.4B
Q4 24
$14.6B
$1.2B
Q3 24
$14.8B
$1.0B
Q2 24
$14.6B
Total Assets
IVZ
IVZ
TEAM
TEAM
Q1 26
$5.7B
Q4 25
$27.1B
$6.2B
Q3 25
$28.4B
$5.7B
Q2 25
$28.5B
$6.0B
Q1 25
$28.1B
$5.9B
Q4 24
$27.0B
$5.4B
Q3 24
$27.5B
$5.0B
Q2 24
$27.2B
Debt / Equity
IVZ
IVZ
TEAM
TEAM
Q1 26
1.13×
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
TEAM
TEAM
Operating Cash FlowLast quarter
$455.8M
$567.5M
Free Cash FlowOCF − Capex
$432.2M
$561.3M
FCF MarginFCF / Revenue
25.5%
31.4%
Capex IntensityCapex / Revenue
1.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
TEAM
TEAM
Q1 26
$567.5M
Q4 25
$455.8M
$177.8M
Q3 25
$606.2M
$128.7M
Q2 25
$547.9M
$375.3M
Q1 25
$-84.6M
$652.7M
Q4 24
$316.9M
$351.9M
Q3 24
$438.4M
$80.5M
Q2 24
$489.1M
Free Cash Flow
IVZ
IVZ
TEAM
TEAM
Q1 26
$561.3M
Q4 25
$432.2M
$168.5M
Q3 25
$586.4M
$114.6M
Q2 25
$530.4M
$360.3M
Q1 25
$-108.0M
$638.3M
Q4 24
$309.9M
$342.6M
Q3 24
$410.0M
$74.3M
Q2 24
$462.4M
FCF Margin
IVZ
IVZ
TEAM
TEAM
Q1 26
31.4%
Q4 25
25.5%
10.6%
Q3 25
35.7%
8.0%
Q2 25
35.0%
26.0%
Q1 25
-7.1%
47.0%
Q4 24
19.5%
26.6%
Q3 24
27.1%
6.3%
Q2 24
31.2%
Capex Intensity
IVZ
IVZ
TEAM
TEAM
Q1 26
0.3%
Q4 25
1.4%
0.6%
Q3 25
1.2%
1.0%
Q2 25
1.2%
1.1%
Q1 25
1.5%
1.1%
Q4 24
0.4%
0.7%
Q3 24
1.9%
0.5%
Q2 24
1.8%
Cash Conversion
IVZ
IVZ
TEAM
TEAM
Q1 26
Q4 25
Q3 25
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
Q2 24
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

TEAM
TEAM

Cloud$1.1B63%
Data Center$560.7M31%
Marketplace and other (1)$93.8M5%

Related Comparisons